Literature DB >> 6624655

Prognosis after myocardial infarction.

A J Moss.   

Abstract

A substantial number of patients die in the first year after myocardial infarction. The major determinants of risk during this period appear to be the extent of either damaged or potentially ischemic myocardium and the degree of electrical instability. Anterior infarction, early left ventricular failure, late significant arrhythmias, and markedly reduced radionuclide left ventricular ejection fraction are the major clinical markers of risk.

Entities:  

Mesh：

Year:  1983        PMID： 6624655     DOI： 10.1016/0002-9149(83)90394-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  Echocardiographic assessment of left ventricular systolic function: from ejection fraction to torsion.

Authors:  Matteo Cameli; Sergio Mondillo; Marco Solari; Francesca Maria Righini; Valentina Andrei; Carla Contaldi; Eugenia De Marco; Michele Di Mauro; Roberta Esposito; Sabina Gallina; Roberta Montisci; Andrea Rossi; Maurizio Galderisi; Stefano Nistri; Eustachio Agricola; Donato Mele
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

2.  An acute study of the electrophysiological and haemodynamic effects of intravenous UK-52,046, a novel alpha 1-adrenoceptor antagonist.

Authors:  E S Barin; C K Wong; J E Elstob; D W Davies; A W Nathan
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

3.  Resting heart rate and risk of sudden cardiac death in the general population: influence of left ventricular systolic dysfunction and heart rate-modulating drugs.

Authors:  Carmen Teodorescu; Kyndaron Reinier; Audrey Uy-Evanado; Karen Gunson; Jonathan Jui; Sumeet S Chugh
Journal:  Heart Rhythm       Date:  2013-05-13       Impact factor: 6.343

Review 4.  Chlamydial infections of the heart.

Authors:  M Odeh; A Oliven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

5.  Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.

Authors:  Valentina Kutyifa; Laszlo Geller; Peter Bogyi; Endre Zima; Mehmet K Aktas; Emin Evren Ozcan; David Becker; Vivien Klaudia Nagy; Annamaria Kosztin; Szabolcs Szilagyi; Bela Merkely
Journal:  Eur J Heart Fail       Date:  2014-11-07       Impact factor: 15.534
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.